Literature DB >> 4095803

Peritoneovenous shunting in intractable ascites.

G T Deans, R A Spence, G W Johnston.   

Abstract

Fourteen patients in whom peritoneovenous shunts were inserted for intractable ascites or malignancy were reviewed.Reduction in ascites was obtained in all patients by the time of discharge with significant diuresis and weight loss. Significant decrease in haemoglobin, packed cell volume, platelet count and prothrombin time also occurred. Coagulation studies were abnormal in 60 per cent of patients in whom they were performed with bruising or detectable bleeding occurring in 28.5 per cent of all patients. Late blockage of the shunt occurred in five patients and was less frequent in Denver than in Le Veen type shunts.Cumulative mortality one month after shunt insertion was 28.5 per cent and at one year was 78.5 per cent reflecting the severity of the underlying disease.Peritoneovenous shunting should be reserved for palliation in patients resistant to full conventional medical therapy.

Entities:  

Mesh:

Year:  1985        PMID: 4095803      PMCID: PMC2448111     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  24 in total

1.  Hepatorenal syndrome: reversal by peritoneovenous shunt.

Authors:  W D Fullen
Journal:  Surgery       Date:  1977-09       Impact factor: 3.982

2.  Coagulopathy following peritoneovenous shunting.

Authors:  M L Schwartz; W R Swaim; S B Vogel
Journal:  Surgery       Date:  1979-06       Impact factor: 3.982

3.  Peritoneo-venous shunting for ascites.

Authors:  H H Leveen; G Christoudias; M Ip; R Luft; G Falk; S Grosberg
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

4.  Dissemination of tumour cells via LeVeen shunt.

Authors:  B Maat; J Oosterlee; J A Spaas; H White; F B Lammes
Journal:  Lancet       Date:  1979-05-05       Impact factor: 79.321

5.  Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites.

Authors:  J D Ansley; R A Bethel; P A Bowen; W D Warren
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

Review 6.  Surgical treatment of ascites.

Authors:  H H LeVeen; T Brown; N G d'Ovidio
Journal:  Adv Surg       Date:  1980

7.  Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.

Authors:  R E Smith; T T Nostrant; F E Eckhauser; J P Wilson; J A Knol; W E Strodel
Journal:  Am J Gastroenterol       Date:  1984-08       Impact factor: 10.864

8.  Complications of peritoneovenous shunt for malignant ascites.

Authors:  J Lokich; R Reinhold; M Silverman; J Tullis
Journal:  Cancer Treat Rep       Date:  1980 Feb-Mar

9.  Peritoneovenous shunting for ascites in cancer patients.

Authors:  J Oosterlee
Journal:  Br J Surg       Date:  1980-09       Impact factor: 6.939

10.  Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts.

Authors:  R G Lerner; J C Nelson; P Corines; L R del Guercio
Journal:  JAMA       Date:  1978-11-03       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.